Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting

454 Views19 Feb 2020 16:25

Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.The company is a dominant heparin supplier on a global scale but it is not...

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 8-minute read)

Discussions

(Paid Plans Only)

Top Quartile

Asia Pac IPO & Placement Research, China biotech

Aequitas Research

EquitiesEquity Capital MarketsQuantitative Analysis

Price Chart(Sign Up to Access)

Insight Stream